This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Purecodon (Hong Kong) Biopharma Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jiafeng Zhu: Innovator in Circular RNA Technology
Introduction
Jiafeng Zhu is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant nucleic acid molecules. His innovative work focuses on the application of transcriptional circular RNA in protein expression.
Latest Patents
Jiafeng Zhu holds a patent for a "Recombinant nucleic acid molecule of transcriptional circular RNA and its application in protein expression." This patent describes a recombinant nucleic acid molecule that produces circular RNA containing a specific IRES element. The IRES element enhances protein expression levels in eukaryotic cells, facilitating efficient and persistent protein production. This technology has important applications in various fields, including the preparation of mRNA infectious disease vaccines, therapeutic mRNA tumor vaccines, and mRNA-based gene therapy.
Career Highlights
Jiafeng Zhu is currently associated with Purecodon (Hong Kong) Biopharma Ltd. His work at the company emphasizes the development of innovative biopharmaceutical solutions. With a focus on advancing RNA technology, he aims to contribute to the future of medical treatments and therapies.
Collaborations
Jiafeng Zhu collaborates with notable colleagues, including Zhenhua Sun and Chijian Zuo. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Jiafeng Zhu's contributions to the field of circular RNA technology represent a significant advancement in biotechnology. His innovative patent and ongoing work at Purecodon Biopharma highlight the potential of RNA-based therapies in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile